Found: 6
Select item for more details and to access through your institution.
Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 Vaccination in Autoimmune Disease (COVAD) study.
- Published in:
- Rheumatology International, 2024, v. 44, n. 10, p. 1923, doi. 10.1007/s00296-024-05682-6
- By:
- Publication type:
- Article
Comment on: Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey: Reply.
- Published in:
- Rheumatology Advances in Practice, 2024, v. 8, n. 3, p. 1, doi. 10.1093/rap/rkae098
- By:
- Publication type:
- Article
COVID-19 vaccine safety during the antenatal period in women with idiopathic inflammatory myopathies.
- Published in:
- Rheumatology, 2023, v. 62, n. 6, p. e175, doi. 10.1093/rheumatology/keac644
- By:
- Publication type:
- Article
Abstract 167: COVID-19 vaccine side effects in Type 1 diabetes mellitus patients as compared to healthy controls: Results from the COVAD study.
- Published in:
- Indian Journal of Endocrinology & Metabolism, 2022, v. 26, p. 71, doi. 10.4103/2230-8210.363672
- By:
- Publication type:
- Article
COVID-19 severity, breakthrough infections and vaccine safety in young individuals with autoimmune diseases: insights from the COVAD study.
- Published in:
- Rheumatology International, 2024, v. 44, n. 9, p. 1725, doi. 10.1007/s00296-024-05654-w
- By:
- Publication type:
- Article
COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group.
- Published in:
- Rheumatology International, 2024, v. 44, n. 1, p. 73, doi. 10.1007/s00296-023-05496-y
- By:
- Publication type:
- Article